# A Different Approach to Preventing Thrombosis

Study · id `cardio:ct-nct02774265` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02774265](<https://clinicaltrials.gov/study/NCT02774265>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02774265

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 329 participants.

## Technical summary

Registry record NCT02774265. Randomized; no masking; primary purpose prevention. Start 2016-01 (actual); primary completion 2017-05 (actual). Results posted on 2018-07-24.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 329 participants (enrolled count; ClinicalTrials.gov record NCT02774265, source copy `cardio:ctgov-nct02774265-2022-01-05`, retrieved 2026-10-31)
- Started: 2016-01 (actual) (ClinicalTrials.gov record NCT02774265, source copy `cardio:ctgov-nct02774265-2022-01-05`, retrieved 2026-10-31)
- Primary completion: 2017-05 (actual) (ClinicalTrials.gov record NCT02774265, source copy `cardio:ctgov-nct02774265-2022-01-05`, retrieved 2026-10-31)
- Completion: 2017-09 (actual) (ClinicalTrials.gov record NCT02774265, source copy `cardio:ctgov-nct02774265-2022-01-05`, retrieved 2026-10-31)
- Results first posted: 2018-07-24 (ClinicalTrials.gov record NCT02774265, source copy `cardio:ctgov-nct02774265-2022-01-05`, retrieved 2026-10-31)
- Countries: United States (ClinicalTrials.gov record NCT02774265, source copy `cardio:ctgov-nct02774265-2022-01-05`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02774265-2022-01-05`, retrieved 2026-10-31)

## The registry's words

- Brief title: A Different Approach to Preventing Thrombosis
- Acronym: ADAPT
- Condition: Venous Thromboembolism
- Condition: Pulmonary Embolism
- Intervention (Drug): VTE prophylaxis with Enoxaparin 30mg BID
- Intervention (Drug): VTE prophylaxis with Aspirin 81mg BID
- Lead sponsor: University of Maryland, Baltimore
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Pulmonary embolism (`cardio:pulmonary-embolism`)
- Registry lists this organization as the lead sponsor: University of Maryland, Baltimore (`cardio:org-university-of-maryland-baltimore`)

## Provenance

Content hash: 2ba690c6c1248de837f263cd15a77f033c558d4b8de1f2f9b3395352d788e931
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
